$10.4 Billion is the total value of HERSHEY TRUST CO's 30 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 85.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PMVP | Sell | PMV PHARMACEUTICALS INC COM | $107,000 | -59.3% | 3,582 | -53.4% | 0.00% | -50.0% |
JNCE | Sell | JOUNCE THERAPEUTICS INC. COM | $126,000 | -15.4% | 16,952 | -22.8% | 0.00% | 0.0% |
AI | Sell | C3 AI INC CL A CL A | $124,000 | -70.3% | 2,667 | -60.0% | 0.00% | -75.0% |
Exit | EVERGRANDE PPTY COMMON STOCK | $0 | – | -38,079 | -100.0% | 0.00% | – | |
APRE | Exit | APREA THERAPEUTICS INC COM | $0 | – | -9,822 | -100.0% | 0.00% | – |
NOAH | Exit | ADR NOAH HLDGS LTD SPONSORED A | $0 | – | -253 | -100.0% | 0.00% | – |
ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC CO | $0 | – | -3,710 | -100.0% | 0.00% | – |
EGRX | Exit | EAGLE PHARMACEUTICALS INC COM | $0 | – | -2,138 | -100.0% | -0.00% | – |
Exit | CHINA RENAISSANCE | $0 | – | -41,286 | -100.0% | -0.00% | – | |
OYST | Exit | OYSTER PT PHARMA INC COM | $0 | – | -8,861 | -100.0% | -0.00% | – |
Exit | JW THERAPEUTICS HKSE COM | $0 | – | -25,113 | -100.0% | -0.00% | – | |
BDTX | Exit | BLACK DIAMOND THERAPEUTICS INC | $0 | – | -12,836 | -100.0% | -0.00% | – |
NRIX | Exit | NURIX THERAPEUTICS INC COM | $0 | – | -8,807 | -100.0% | -0.00% | – |
PACB | Exit | PACIFIC BIOSCIENCES OF CALIFOR | $0 | – | -5,258 | -100.0% | -0.00% | – |
CRNX | Exit | CRINETICS PHARMACEUTICALS INC | $0 | – | -19,778 | -100.0% | -0.00% | – |
EB | Exit | EVENTBRITE INC COM CL A | $0 | – | -17,343 | -100.0% | -0.00% | – |
MOMO | Exit | MOMO INC ADR | $0 | – | -19,998 | -100.0% | -0.00% | – |
CRWD | Exit | CROWDSTRIKE HLDGS INC CL A CL | $0 | – | -1,563 | -100.0% | -0.00% | – |
RPTX | Exit | REPARE THERAPEUTICS INC COM | $0 | – | -24,728 | -100.0% | -0.01% | – |
RLAY | Exit | RELAY THERAPEUTICS INC COM | $0 | – | -59,360 | -100.0% | -0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HERSHEY COMPANY (THE) - CLASS B | 42 | Q3 2023 | 99.9% |
HERSHEY COMPANY COM STK USD1 | 39 | Q3 2023 | 17.4% |
Marathon Oil Corp | 26 | Q1 2021 | 0.0% |
ADR NOAH HOLDINGS LTD | 20 | Q2 2021 | 0.0% |
ADR VIPSHOP HLDGS LTD SPONSORED | 17 | Q4 2017 | 0.0% |
EAGLE PHARMACEUTICALS INC COM | 17 | Q2 2021 | 0.0% |
MOMO INC ADR | 16 | Q2 2021 | 0.0% |
CRISPR THERAPEUTICS AG COM CHF | 13 | Q3 2023 | 0.0% |
ZENDESK INC | 13 | Q3 2017 | 0.0% |
MICROSOFT CORP COM | 11 | Q4 2022 | 0.0% |
View HERSHEY TRUST CO's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
SC 13G | 2023-02-14 |
13F-HR | 2022-11-15 |
4 | 2022-11-10 |
13F-HR | 2022-08-15 |
View HERSHEY TRUST CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.